We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
+9.68%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$11.7B
AUM Growth
+$519M
Cap. Flow
-$211M
Cap. Flow %
-1.8%
Top 10 Hldgs %
22.25%
Holding
2,987
New
14
Increased
385
Reduced
2,541
Closed
40

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$13.8M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$13.3M
3
AAPL icon
Apple
AAPL
+$12.7M
4
MSFT icon
Microsoft
MSFT
+$11.8M
5
JNJ icon
Johnson & Johnson
JNJ
+$10.5M

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 13.77%
3 Financials 12.54%
4 Consumer Discretionary 11.05%
5 Industrials 10.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOND
2651
DELISTED
Sonder
SOND
$20K ﹤0.01%
1,333
-199
-13% -$4.62K
VERA icon
2652
Vera Therapeutics
VERA
$2.37B
$20K ﹤0.01%
2,595
+392
+18% +$3.03K
VLGEA icon
2653
Village Super Market
VLGEA
$651M
$20K ﹤0.01%
880
-196
-18% -$4.49K
WLDN icon
2654
Willdan Group
WLDN
$1.06B
$20K ﹤0.01%
1,249
-240
-16% -$4.3K
TBCH
2655
Turtle Beach Corp
TBCH
$243M
$20K ﹤0.01%
2,023
-333
-14% -$2.83K
HLTH
2656
DELISTED
Cue Health Inc. Common Stock
HLTH
$20K ﹤0.01%
11,216
-2,431
-18% -$5.28K
NGM
2657
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$20K ﹤0.01%
5,022
-795
-14% -$3.67K
LVOX
2658
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$20K ﹤0.01%
6,449
-495
-7% -$1.31K
BLND icon
2659
Blend Labs
BLND
$424M
$19K ﹤0.01%
19,394
-4,037
-17% -$6.18K
BRCC icon
2660
BRC Inc
BRCC
$119M
$19K ﹤0.01%
3,712
-454
-11% -$2.85K
CIFR icon
2661
Cipher Digital
CIFR
$9.27B
$19K ﹤0.01%
7,947
-843
-10% -$1.3K
CPNG icon
2662
Coupang
CPNG
$28.9B
$19K ﹤0.01%
1,159
-108
-9% -$1.67K
EGAN icon
2663
eGain
EGAN
$183M
$19K ﹤0.01%
2,491
-459
-16% -$3.95K
IGMS
2664
DELISTED
IGM Biosciences
IGMS
$19K ﹤0.01%
1,369
-215
-14% -$4.45K
INVE icon
2665
Identive
INVE
$64.8M
$19K ﹤0.01%
3,055
-464
-13% -$3.42K
KALV
2666
DELISTED
KalVista Pharmaceuticals
KALV
$19K ﹤0.01%
2,436
-568
-19% -$4.24K
PKBK icon
2667
Parke Bancorp
PKBK
$396M
$19K ﹤0.01%
1,047
-234
-18% -$4.66K
RENT
2668
Rent the Runway
RENT
$119M
$19K ﹤0.01%
330
-46
-12% -$3.22K
FIRY
2669
Firy Inc
FIRY
$152M
$19K ﹤0.01%
1,607
-383
-19% -$5.08K
STOK icon
2670
Stoke Therapeutics
STOK
$1.87B
$19K ﹤0.01%
2,333
-520
-18% -$4.69K
TLS icon
2671
Telos
TLS
$324M
$19K ﹤0.01%
7,515
-1,132
-13% -$4.62K
TNGX icon
2672
Tango Therapeutics
TNGX
$4.49B
$19K ﹤0.01%
4,825
-1,081
-18% -$6.27K
KNTE
2673
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$19K ﹤0.01%
3,037
-677
-18% -$4.13K
CRGE
2674
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
$19K ﹤0.01%
17,162
-2,728
-14% -$3.44K
ACET icon
2675
Adicet Bio
ACET
$84.7M
$18K ﹤0.01%
191
-50
-21% -$6.28K

Similar funds

Amalgamated Bank's Q1 2023 Portfolio in Review

As of Q1 2023, Amalgamated Bank held 2,987 positions worth $11.7B, up 4.6% from $11.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 1.8%. Amalgamated Bank opened 14 new positions and exited 40, leaving the 2,987-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Amalgamated Bank's largest Q1 2023 buy was GE HealthCare: 94,072 shares worth $7.72M.
  • Amalgamated Bank added most to ExxonMobil in Q1 2023, an estimated $13.8M increase.
  • Amalgamated Bank's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $7.05M.
  • Amalgamated Bank fully exited STORE Capital Corporation in Q1 2023, selling an estimated $6.13M.
  • Amalgamated Bank's ten largest holdings make up 22% of its $11.7B portfolio in Q1 2023.
  • Amalgamated Bank opened 14 new positions and closed 40 in Q1 2023.
  • Amalgamated Bank's portfolio value rose 4.6% quarter-over-quarter to $11.7B.

Based on Amalgamated Bank's 13F filing for Q1 2023, filed 2 May 2023.